Answers are grounded in this paper and cite their sources.
Endothelin A-antagonist treatment at the time of reperfusion significantly limited the progressive decrease in postischemic microvascular reflow and the increase in myocardial thickness. MCE allowed a reliable evaluation of pharmacologically induced changes in microvascular flow.
No takes yet. Share an insight, caveat, or question.
Galiuto et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: